医疗诊断市场中的人工智能基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00011852
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 208
Buy Now

全球人工智能医疗诊断市场规模预计将从 2019 年的 36.3902 亿美元增至 2027 年的 668.1197 亿美元。预计 2020 年至 2027 年该市场将以 44.0% 的复合年增长率增长。

人工智能 (AI) 巧妙地集成了多种技术,能够在无需人工干预的情况下执行任务。医疗保健行业已广泛采用人工智能,政府通过越来越多的举措对这一创新给予了大力支持。

医疗保健行业正在快速增长,主要是由于新的和未知的慢性疾病的出现与全球变暖之前的时代相比,频率有所增加。医疗保健专业人员的短缺以及疾病数量的迅速增加造成了巨大的压力,导致人为错误的发生。人工智能旨在减少医疗保健专业人员的工作量。基于人工智能的初创企业正在获得政府的大量投资,这为人工智能在医疗诊断市场的增长提供了所需的推动力。

COVID-19 的影响

医疗保健行业见证了许多震撼整个行业的疫情爆发,但没有一次像 COVID-19 大流行那样将全球行业推向不确定性。事实证明,人工智能是我们应对疫情最有效的工具;因此,人工智能在医疗诊断市场的增长势在必行。在世界意识到病毒性疾病 (COVID-19) 构成的威胁之前,人工智能 (AI) 系统就检测到中华人民共和国(以下简称“中国”)爆发了一种未知类型的肺炎。人工智能在快速分析大量数据方面具有巨大潜力,这一特性可能在流行病等情况下产生重大影响。数据解释的精确性进一步减少了人类难以避免的错误范围。

未来趋势

当涉及传染病时,通常会出现广泛的恐慌,这会加剧最近由于 COVID-19 大流行。人们已经认识到旧的方法已经不够了。事实证明,人工智能是支持抗击自 2020 年以来席卷全球的病毒大流行的有效解决方案。在预测期内,采用人工智能进行疫情爆发预测和应对可能会成为市场的普遍趋势。从目前的反应来看,全球人工智能在医疗诊断市场可能会经历巨大的增长。

驱动因素

人工智能 (AI) 在疾病识别和诊断中的采用率不断上升

医疗保健行业是创新的先锋。然而,医疗保健很难掌握病原体反复发生的突变,这些突变会每隔几年就会引发新的疾病。在这种不稳定的情况下,机器学习和人工智能算法是完美的工具。它带来的持续进步和精确度对临床实践产生了持久的影响。例如,深度学习可以帮助识别胸部 X 光片中的异常情况。病理学家正在采用人工智能来准确识别人体内健康细胞中的癌细胞。作为布拉格国际生物医学成像研讨会竞赛的一部分,哈佛大学团队的一项基于人工智能的技术实现了 99.5% 的癌症早期诊断。基于人工智能的系统的成功推动了其在各个领域的采用。这为人工智能在医疗诊断市场带来了当之无愧的推动力。

加大对人工智能医疗初创企业的投资

人工智能在医疗领域的积极影响是显而易见的。这使得许多感兴趣的公司,无论是老牌公司还是初创公司,都进入了市场舞台。人工智能在医疗诊断市场的巨大潜力也吸引了政府机构的关注,政府机构纷纷发布投资和公私合作计划,激励许多企业投资这一市场领域。这创造了一个增长周期,随后更多的公司开发人工智能驱动的技术,最终将市场增长推向前所未有的高度。

限制

缺乏熟练的人工智能劳动力和模糊的监管医疗软件指南

随着医疗保健部门加速采用人工智能技术,我们注意到了一个意想不到的问题。人工智能的使用需要非常专业的知识和技能。缺乏额外的合格人工智能员工是整个业务运营中人工智能实施的最大障碍。 Element AI(人工智能公司)在 2019 年估计,全球只有不到 10,000 人拥有创建功能齐全的机器学习系统所需的技能。学术和培训项目无法跟上人工智能创新和发现的步伐此外,目前还没有针对人工智能在临床应用中实施的正式监管框架。人工智能系统需要经过彻底的测试,并且在应用于临床实践之前应根据敏感性和特异性发布结果,以确保患者的安全。不需要监管的深度学习技术系统很难获得 FDA 的批准。

战略洞察

市场细分

通过诊断工具

医疗影像工具需求不断增长,形成细分市场主导地位

医疗诊断市场中的人工智能,按诊断工具细分为医疗影像工具、自动检测系统等。综上所述,医疗成像工具领域在 2019 年占据市场主导地位,收入份额最大,预计在预测期内复合年增长率最高。医学成像工具包括磁共振成像、计算机断层扫描 (CT)、医学超声检查或超声波、X 射线照相以及核医学功能成像技术,例如正电子发射断层扫描 (PET)。该类别中工具的多样性及其不断增长的需求推动了细分市场的增长。

医疗诊断市场中的全球人工智能,由 Diagnostic Tool 提供2019年和2027年

按应用划分

手动床的广泛应用刺激细分市场增长

从应用来看,人工智能在医疗诊断市场分为眼科、肿瘤科、放射科、心血管科等。 2019年,肿瘤学领域占据最大的市场份额。该细分市场可能在预测期内快速增长。癌症是我们世界面临的最大健康问题。人工智能的协助,推动了肿瘤诊断进程。众所周知,在这种情况下,早期发现可以成倍提高患者的生存机会。癌症研究因其发病率不断上升而成为重中之重,人工智能在该领域的应用推动了人工智能在癌症领域医疗保健诊断中的增长。

区域洞察

按地理分布全球人工智能医疗诊断市场包括北美、欧洲、亚太地区(APAC)、中东和美国。非洲 (MEA) 和南美洲中美洲(SCAM)。

北美在 2019 年医疗诊断市场的人工智能领域占据主导地位,拥有最显着的业务份额和占有率。美国拥有最大的市场份额,其次是加拿大。美国市场的增长是由减少医疗费用的需求、大数据在医疗保健中日益重要以及不断增加的资本投资等因素推动的。同样,在加拿大,越来越多的政府举措实施基于人工智能的技术正在促进市场增长。

亚太地区医疗保健诊断市场中的人工智能预计在未来几年将以最高的复合年增长率扩张,因为中国和印度等国家的人口在该地区下降。老年人口的增加和慢性病患病率的增加促使这些发展中国家更加关注医疗保健系统。由于医疗保健专业人员的短缺,他们正在积极采用人工智能,促进人工智能在医疗诊断市场的增长。

医疗诊断中人工智能的区域市场利润丰厚

主要市场参与者

  • 通用电气公司。 (美国)
  • Koninklijke Philips NV(荷兰)
  • Aidoc(以色列)
  • Arterys Inc.(美国)
  • Icometrix(比利时) )
  • Siemens Healthcare Private Limited(德国)
  • MaxQ AI Ltd.(以色列)
  • Caption Health, Inc.(美国)
  • IDx Technologies Inc.(美国)
  • Zebra Medical Vision, Inc.(以色列)

主要进展:

  • 2020 年 5 月:Aidoc 获得美国食品和药物管理局的批准,可以使用该公司的算法对与 COVID-19 相关的结果进行“辅助”检测。该解决方案是支持传统 COVID-19 诊断测试(例如血清学测试、鼻咽拭子等)的模型之一。
  • 2019 年 9 月:GE Healthcare 获得 510(k) 许可荣获美国食品和药物管理局颁发的“重症监护套件”。它是业界首个嵌入移动 X 射线设备的人工智能 (AI) 算法集合。
  • 2019 年 2 月:Affidea 和 icometrix 建立战略合作伙伴关系,旨在标准化和开发必要的算法为欧洲神经系统疾病患者提供护理。
  • 2019 年 10 月:Arterys Inc. 推出 Cardio AI 解决方案,结合深度学习和云计算来自动分析心脏 MR 图像。

报告覆盖范围

全球人工智能医疗诊断市场研究报告提供了有关规模、份额、趋势和预测的详细见解。它提供了关于驱动因素、限制因素、机会、细分市场和产业格局的清晰而准确的专业知识。全球和区域市场洞察提供当前和未来的行业场景,以确定投资决策。一些主要市场参与者及其近年来各自的发展已被保留为特别提及。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the artificial intelligence in healthcare diagnosis?

Artificial intelligence (AI) uses algorithms and software to perform certain tasks without human intervention and instructions. Artificial intelligence comprises integration of several technologies such as machine learning, natural language processing, reasoning, and perception. Artificial intelligence is used in healthcare for approximation of human cognition and analysis of complex medical and diagnostic imaging data. The artificial intelligence in the healthcare diagnosis market is driven by the ability of AI to improve patient outcomes, need to increase coordination between healthcare workforce & patients.

What are the driving factors for the artificial intelligence in healthcare diagnosis market across the globe?

The global artificial intelligence in healthcare diagnosis market is being driven by factors such as rising adoption of artificial intelligence (AI) in disease identification and diagnosis, increasing investment in AI healthcare startups. Furthermore, increasing potential in emerging economies is likely to offer significant opportunities for the growth of the global artificial intelligence in healthcare diagnosis market.

What are the restraining factors for the artificial intelligence in healthcare diagnosis market across the globe?

The lack of skilled ai workforce and ambiguous regulatory guidelines for medical software is the significant factor that will hinder the artificial intelligence in healthcare diagnosis market growth.

The List of Companies - Artificial Intelligence in Healthcare Diagnosis Market

 

  1. General Electric Company
  2.  Aidoc
  3. Arterys Inc.
  4. Icometrix
  5. IDx Technologies Inc
  6. MaxQ AI Ltd.
  7. Caption Health, Inc.
  8. Zebra Medical Vision Inc.
  9. Siemens Healthineers AG
  10. Koninklijke Philips N.V

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports